What Alexion Pharmaceuticals, Inc. pays H-1B Associate Scientists
Alexion Pharmaceuticals, Inc. filed 12 certified H-1B LCAs for Associate Scientist roles in FY2025-FY2026. In FY2026 (October to June), the middle half of its 6 filings stated $94,211 to $100,920 a year, with a median of $99,689.
Median, FY2026 so far$99,689
Middle half$94,211 to $100,920
Certified LCAs, FY2025-FY202612
By fiscal year
| Year | LCAs | Median | Middle half | Lowest to highest | Prevailing wage |
|---|---|---|---|---|---|
| FY2026 so far | 6 | $99,689 | $94,211 to $100,920 | $91,795 to $118,183 | $74,110 |
| FY2025 | 6 | $95,209 | $88,806 to $100,307 | $87,210 to $101,444 | $77,730 |
Prevailing wage is the median of the DOL prevailing wage on the same filings: the floor the law sets for that job and place.
By prevailing-wage level
| Level | LCAs | Median | Middle half |
|---|---|---|---|
| Level I (entry) | 11 | $96,900 | $92,152 to $100,633 |
| Level II (qualified) | 1 | $118,183 | too few |
Level I is entry and Level IV is fully competent, as the employer classified the position. Seniority words in the job title are folded into one title here; the level is where seniority shows.
By worksite
| Worksite | LCAs | Median | Lowest to highest |
|---|---|---|---|
| New Haven, CT | 12 | $98,110 | $87,210 to $118,183 |
Titles grouped here
- Associate Scientist III (3)
- Associate Scientist II, Upstream Process Development (2)
- Associate Scientist III, Biologic Drug Substance Development (1)
- Associate Scientist II (1)
- Associate Scientist III, Upstream Process Development (1)
- Associate Scientist III, New Capabilities Process Dev, Upstr (1)
- Associate Scientist II, Injectable Drug Product Development (1)
- Associate Scientist II, IVIVP (1)
Filed as Biochemists and Biophysicists (SOC 19-1021).
Applying to Alexion Pharmaceuticals, Inc.?
Nyanza puts these filings next to any Associate Scientist posting you check, so you know what the employer has stated before the first call.